Wikidata

(Q61915255)

English

A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and Pioglitazone,in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2)

clinical trial

In more languages

Statements

title
A Randomized, Double-Blind, Parallel-Group, Multicenter Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Long-Acting Release(Once Weekly) to Those of Sitagliptin and a Thiazolidinedione in Subjects With Type 2 Diabetes Mellitus Treated With Metformin (English)
0 references
sponsor
AstraZeneca
0 references
country
India
0 references
Mexico
0 references
main subject
diabetes
0 references
start time
January 2008
0 references
end time
February 2009
0 references
number of participants
514
0 references
research intervention
pioglitazone
0 references
exenatide
0 references
2,4-thiazolidinedione
0 references
metformin
0 references
sitagliptin phosphate
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61915255&oldid=2109367743"